Global disease burden attributable to kidney dysfunction, 1990–2019: A health inequality and trend analysis based on the global burden of disease study

Diabetes Res Clin PractPublished Secondary analysis of the Global Burden of Disease Study 2019

Authors' conclusion

The disease burden of KD remained serious. Tailored interventions should be developed based on national contexts.

Study context

Population
Global population, Global Burden of Disease Study 2019 data on deaths, disability-adjusted life years (DALYs), years lived with disability (YLDs) and years of life lost (YLLs) attributable to kidney dysfunction (KD), cross-country comparisons
Methodological detailsJoinpoint regression, slope index and concentration index, age-period-cohort projection
  • Joinpoint regression
  • Slope index and concentration index
  • Age-period-cohort projection

Primary result

As reported in the abstract

Burden attributable to KD: deaths, DALYs, YLDs and YLLs · past three decades
Deaths increased
from 1,571,720 to 3,161,552
DALYs increased
from 42,090,331 to 76,486,945
YLDs increased
from 5,003,267 to 11,282,484
YLLs increased
from 37,087,065 to 65,204,461
Slope index for DALYs increased
from 248.1 to 351.9
Concentration index for DALYs increased
from 40.70 to 57.8

Further findings

Cross-country inequality in DALYs

Slope index increased
248.1 to 351.9
Concentration index increased
40.70 to 57.8

Projected future trend

Age-standardized rates of deaths, DALYs, YLDs and YLLs will remain stable; numbers will continue to rise, except YLLs

Original publication

Global disease burden attributable to kidney dysfunction, 1990–2019: A health inequality and trend analysis based on the global burden of disease study. Diabetes Res Clin Pract. Published 31 July 2024. doi:10.1016/j.diabres.2024.111801

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.